The project for the designation of Centers, Services and Reference Units (CSUR) of the National Health System (SNS) aims to improve equity in access to high-level services, concentrate the experience of high-level of specialization ensuring quality, safe, and efficient health care, improve procedures and care for pathologies with low prevalence. On June 30, 2021, the Interterritorial Council of the National Health System has approved the agreement of the Committee of designation of CSUR for the designation of 21 new CSUR:
- Six for systemic autoimmune diseases;
- Three for hereditary angioedema;
- Four for primary immunodeficiencies (adults and children);
- Three for autoinflammatory diseases;
- One for pediatric vitreoretinal surgery;
- Two for complex cataract in children;
- Two for hereditary retinal dystrophies.
In addition, the designation of six CSUR for comprehensive care of adults with congenital heart disease will be renewed.
See the press release by the Ministry of Health, Consumption and Social Welfare in Spanish here. The full details regarding the CSUR of the SNS in Spanish can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.